Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Two-part Study Exploring the Efficacy, Safety, and Pharmacodynamics of Acthar in Systemic Lupus Erythematosus Patients With a History of Persistently Active Disease

NCT01753401 is registered in ClinicalTrials.gov with Mallinckrodt as lead sponsor.

NCT NCT01753401
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01753401 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Two-part Study Exploring the Efficacy, Safety, and Pharmacodynamics of Acthar in Systemic Lupus Erythematosus Patients With a History of Persistently Active Disease
Lead sponsor
Mallinckrodt
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2013
Completion date
October 31, 2015
Enrollment
38 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

systemic lupus erythematosus (sle)